Vycor Medical, Inc., a leading innovator in the medical device industry, is headquartered in the United States, with significant operations across North America and Europe. Founded in 2005, the company has established itself as a pioneer in neurosurgical solutions, particularly through its flagship product, the VisionPort® system. This unique device enhances minimally invasive surgical procedures by providing surgeons with improved access and visibility. With a strong focus on advancing patient care, Vycor Medical has achieved notable milestones, including regulatory approvals and partnerships that bolster its market position. The company is recognised for its commitment to innovation, making it a trusted name among healthcare professionals seeking cutting-edge solutions in neurosurgery.
How does Vycor Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Vycor Medical, Inc.'s score of 18 is lower than 75% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Vycor Medical, Inc., headquartered in the US, currently does not report any specific carbon emissions data, as indicated by the absence of emissions figures in kg CO2e. The company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing its carbon footprint at this time. As a current subsidiary, Vycor Medical, Inc. may inherit climate-related data and initiatives from its parent organisation; however, no specific details regarding such cascaded data have been provided. This absence of information limits the ability to assess the company's climate commitments or performance in relation to industry standards. In the broader context, companies in the medical technology sector are increasingly recognising the importance of sustainability and climate action. While Vycor Medical, Inc. has not yet made public commitments or reported emissions, the industry trend indicates a growing emphasis on reducing carbon emissions and enhancing environmental responsibility.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Vycor Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.